Identification of the Main Chemical constituents and mechanism of Renshen Guben oral liquid against Renal Fibrosis

Identification of the Main Chemical constituents and mechanism of Renshen Guben oral liquid against Renal Fibrosis

Abstract Background Renal fibrosis is the late stage of many chronic kidney diseases (CKD). Clinically, there is almost no effective treatment for renal fibrosis except dialysis. Renshen Guben oral liquid (RSGB) is a Chinese patent medicine approved by National Medical Products Administration (NMPA)...

Full description

Bibliographic Details
Main Authors: Junhong Zhang, Juqin Peng, Tong Zhang, Hong Jiang, Yuewen Qin, Hong Chen, Xiaofang Deng, Junguo Ren, Ping Wang, Haiyu Xu
Format: Article
Language:English
Published: BMC 2023-05-01
Series:Chinese Medicine
Subjects:
RSGB
UPLC-QTOF-MS/MS
UUO model
RNA sequencing
“Constituents-targets-pathways” network
Online Access:https://doi.org/10.1186/s13020-023-00762-4

Internet

https://doi.org/10.1186/s13020-023-00762-4

Similar Items